1. Home
  2. XNCR vs VMEO Comparison

XNCR vs VMEO Comparison

Compare XNCR & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • VMEO
  • Stock Information
  • Founded
  • XNCR 1997
  • VMEO 2004
  • Country
  • XNCR United States
  • VMEO United States
  • Employees
  • XNCR N/A
  • VMEO N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • VMEO Computer Software: Prepackaged Software
  • Sector
  • XNCR Health Care
  • VMEO Technology
  • Exchange
  • XNCR Nasdaq
  • VMEO Nasdaq
  • Market Cap
  • XNCR 547.8M
  • VMEO 652.9M
  • IPO Year
  • XNCR 2013
  • VMEO N/A
  • Fundamental
  • Price
  • XNCR $13.61
  • VMEO $7.77
  • Analyst Decision
  • XNCR Buy
  • VMEO Hold
  • Analyst Count
  • XNCR 11
  • VMEO 4
  • Target Price
  • XNCR $22.20
  • VMEO $6.81
  • AVG Volume (30 Days)
  • XNCR 1.3M
  • VMEO 3.1M
  • Earning Date
  • XNCR 11-05-2025
  • VMEO 11-03-2025
  • Dividend Yield
  • XNCR N/A
  • VMEO N/A
  • EPS Growth
  • XNCR N/A
  • VMEO N/A
  • EPS
  • XNCR N/A
  • VMEO 0.08
  • Revenue
  • XNCR $146,929,000.00
  • VMEO $415,404,000.00
  • Revenue This Year
  • XNCR $23.31
  • VMEO $2.98
  • Revenue Next Year
  • XNCR N/A
  • VMEO $5.12
  • P/E Ratio
  • XNCR N/A
  • VMEO $100.62
  • Revenue Growth
  • XNCR N/A
  • VMEO N/A
  • 52 Week Low
  • XNCR $6.92
  • VMEO $3.64
  • 52 Week High
  • XNCR $27.24
  • VMEO $7.90
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 88.43
  • VMEO 87.71
  • Support Level
  • XNCR $11.36
  • VMEO $7.75
  • Resistance Level
  • XNCR $13.07
  • VMEO $7.80
  • Average True Range (ATR)
  • XNCR 0.63
  • VMEO 0.02
  • MACD
  • XNCR 0.16
  • VMEO -0.12
  • Stochastic Oscillator
  • XNCR 94.92
  • VMEO 56.25

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About VMEO Vimeo Inc.

Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. The comprehensive and cloud-based tools of the company empower its users to create, share, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.

Share on Social Networks: